Bellini Roberto

Bellini Roberto is listed in filings as Director at Inhibikase Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 2, 2025, including purchase activity. Recent filings connect the profile to Inhibikase Therapeutics, Inc. (IKT). The current snapshot covers public activity from Oct 23, 2024 to Jul 2, 2025. Reported amounts are shown as $210.9K to $172.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.